Related Experiment Video
Updated: May 21, 2026
09:06
Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
Melatonin as add-on treatment for epilepsy
Francesco Brigo1, Alexandra Del Felice
1Department of Neurological, Neuropsychological, Morphological andMovement Sciences. Section of Clinical Neurology, Universityof Verona, Verona, Italy. 2Policlinico G.B. Rossi, Verona, Italy.dr.francescobrigo@gmail.com.
The Cochrane Database of Systematic Reviews
|June 15, 2012
Summary
Melatonin did not show efficacy as an add-on treatment for epilepsy in this review. Poor study quality prevented definitive conclusions on seizure reduction or quality of life improvements.
Area of Science:
- Neurology
- Pharmacology
Background:
- Epilepsy affects many individuals, with a significant percentage unresponsive to current antiepileptic drugs (AEDs).
- Existing AEDs can cause adverse effects, necessitating the search for better-tolerated alternatives.
- Melatonin has been suggested as a potential antiepileptic agent with a favorable safety profile.
Purpose of the Study:
- To evaluate the effectiveness and tolerability of melatonin when used as an adjunctive therapy for epilepsy.
Main Methods:
- A systematic review of randomized controlled trials was conducted using major databases and trial registers.
- Studies included participants of all ages with epilepsy receiving melatonin as add-on therapy versus placebo.
- Outcomes assessed included seizure reduction, seizure freedom, adverse events, and quality of life.
Main Results:
- Four studies with 102 participants (mostly children) were included.
- Insufficient data precluded meta-analysis; narrative summaries were used.
- No significant improvement in seizure frequency or quality of life was observed. Adverse events were poorly reported.
Conclusions:
- The included studies were of low methodological quality.
- Inadequate systematic evaluation of seizure frequency and adverse events prevented meta-analysis.
- No definitive conclusions can be drawn regarding melatonin's efficacy or impact on quality of life in epilepsy management.
Related Concept Videos
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...